Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILIMSIR: Oral Inflammation, Microbiota and Systemic Immune Responses
NCT06966492Phase 4Not yet recruiting
- Sponsor
- Colgate-Palmolive
- Start
- Sep 2026
- Primary completion
- Jun 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of stannous fluoride in gingivitis, sponsored by Colgate-Palmolive. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
stannous fluoride
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT06966492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06966492.